Skip to main content
Clinical Trials/NCT05852015
NCT05852015
Completed
N/A

Digital Mindfulness-Based Treatment for Individuals in Early Recovery From Substance Use Disorders

Yale University1 site in 1 country36 target enrollmentMay 18, 2023

Overview

Phase
N/A
Intervention
Not specified
Conditions
Substance Use Disorders
Sponsor
Yale University
Enrollment
36
Locations
1
Primary Endpoint
Adherence to the digital treatment
Status
Completed
Last Updated
11 months ago

Overview

Brief Summary

The goal of this clinical trial is to evaluate the feasibility and acceptability of a digital mindfulness-based treatment for individuals in early recovery from substance use disorders. Participants are randomized to treatment-as-usual (TAU) or TAU plus the digital mindfulness-based treatment. The digital treatment will be completed over an 8-week period.

Registry
clinicaltrials.gov
Start Date
May 18, 2023
End Date
February 1, 2025
Last Updated
11 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Corey Roos

Assistant Professor of Psychiatry

Yale University

Eligibility Criteria

Inclusion Criteria

  • 18 years of age or older
  • Fluent in English and have a 6th grade or higher reading level
  • Have completed 1 month or more of SUD treatment
  • Report use of their primary substance of choice in past 6 months
  • Are not currently enrolled in residential/inpatient treatment
  • Are willing to be randomized
  • Are willing and able to participate for the entire study period
  • Are willing to provide locator information for follow-up
  • Own a working, WIFI-enabled smartphone

Exclusion Criteria

  • Current psychotic disorder
  • High suicide risk characterized by suicidal ideation with intent
  • Homicidal ideation posing imminent danger to others
  • Pending legal case, imminent incarceration, or a planned move that results in inability to commit to procedures during the entire study period
  • Participation in the Phase 1 User Testing study

Outcomes

Primary Outcomes

Adherence to the digital treatment

Time Frame: 8-week treatment period that begins on the day participants are randomized

Percent of randomized participants completing 50% or more of the digital treatment modules

Completion rates for the follow-up assessment visit

Time Frame: 2-month post-treatment follow-up (approximately 16 weeks post-randomization)

Percent of randomized participants completing follow-up assessment visit

Completion rates for ecological momentary assessment at post-treatment

Time Frame: 2-week period occurring approximately during weeks 10 and 11 post-randomization

Percent of randomized participants completing 50% or more of EMA surveys post-treatment

Completion rates for the post-treatment assessment visit

Time Frame: Approximately 9 weeks after randomization

Percent of randomized participants completing post-treatment assessment visit

Completion rates for ecological momentary assessment at baseline

Time Frame: 2-week period at baseline prior to randomization

Percent of randomized participants completing 50% or more of EMA surveys at baseline

Dimensions of treatment acceptability

Time Frame: Ratings made at the post-treatment assessment, which is approximately 9 weeks after randomization

Single-items measuring ratings of acceptability dimensions for the digital treatment, including willingness to engage, usability, understandability, engage-ability, visual appeal, helpfulness, skill acquisition, and confidence implementing skills. Scores for each item range from 1 to 5, with higher scores indicating better acceptability.

Study Sites (1)

Loading locations...

Similar Trials